JP2013532677A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532677A5 JP2013532677A5 JP2013521146A JP2013521146A JP2013532677A5 JP 2013532677 A5 JP2013532677 A5 JP 2013532677A5 JP 2013521146 A JP2013521146 A JP 2013521146A JP 2013521146 A JP2013521146 A JP 2013521146A JP 2013532677 A5 JP2013532677 A5 JP 2013532677A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- formulation
- composition according
- pharmaceutically acceptable
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 24
- 239000000203 mixture Substances 0.000 claims 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 12
- 238000009472 formulation Methods 0.000 claims 9
- 239000011734 sodium Substances 0.000 claims 9
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 239000011780 sodium chloride Substances 0.000 claims 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 4
- 239000003755 preservative agent Substances 0.000 claims 4
- 230000002335 preservative effect Effects 0.000 claims 4
- 229910052783 alkali metal Inorganic materials 0.000 claims 3
- -1 alkali metal cation Chemical class 0.000 claims 3
- 239000012669 liquid formulation Substances 0.000 claims 3
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims 3
- 230000000087 stabilizing effect Effects 0.000 claims 2
- 239000007972 injectable composition Substances 0.000 claims 1
- 230000006641 stabilisation Effects 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10171428.5 | 2010-07-30 | ||
| EP10171428A EP2417982A1 (en) | 2010-07-30 | 2010-07-30 | Stabilization of gonadotropins |
| PCT/EP2011/062986 WO2012013742A2 (en) | 2010-07-30 | 2011-07-28 | Stabilization of fsh |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015245748A Division JP2016102127A (ja) | 2010-07-30 | 2015-12-17 | Ｆｓｈの安定化 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532677A JP2013532677A (ja) | 2013-08-19 |
| JP2013532677A5 true JP2013532677A5 (enExample) | 2014-09-11 |
| JP5860047B2 JP5860047B2 (ja) | 2016-02-16 |
Family
ID=43216624
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013521146A Active JP5860047B2 (ja) | 2010-07-30 | 2011-07-28 | Ｆｓｈの安定化 |
| JP2015245748A Pending JP2016102127A (ja) | 2010-07-30 | 2015-12-17 | Ｆｓｈの安定化 |
| JP2017212395A Active JP6522711B2 (ja) | 2010-07-30 | 2017-11-02 | Ｆｓｈの安定化 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015245748A Pending JP2016102127A (ja) | 2010-07-30 | 2015-12-17 | Ｆｓｈの安定化 |
| JP2017212395A Active JP6522711B2 (ja) | 2010-07-30 | 2017-11-02 | Ｆｓｈの安定化 |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US8993732B2 (enExample) |
| EP (3) | EP2417982A1 (enExample) |
| JP (3) | JP5860047B2 (enExample) |
| KR (2) | KR101820115B1 (enExample) |
| CN (2) | CN103052398B (enExample) |
| AR (1) | AR082776A1 (enExample) |
| AU (1) | AU2011284702C1 (enExample) |
| BR (1) | BR112013002312B1 (enExample) |
| CA (1) | CA2805864A1 (enExample) |
| DK (1) | DK2598160T3 (enExample) |
| ES (1) | ES2623634T3 (enExample) |
| HR (1) | HRP20170386T1 (enExample) |
| HU (1) | HUE033592T2 (enExample) |
| IL (2) | IL223821A (enExample) |
| JO (1) | JO3229B1 (enExample) |
| LT (1) | LT2598160T (enExample) |
| MX (2) | MX356951B (enExample) |
| NZ (2) | NZ606366A (enExample) |
| PL (1) | PL2598160T3 (enExample) |
| PT (1) | PT2598160T (enExample) |
| RS (1) | RS55772B1 (enExample) |
| RU (1) | RU2574012C2 (enExample) |
| SA (1) | SA114350786B1 (enExample) |
| SI (1) | SI2598160T1 (enExample) |
| TW (1) | TWI439283B (enExample) |
| WO (1) | WO2012013742A2 (enExample) |
| ZA (1) | ZA201209497B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI488640B (zh) | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
| EP2417982A1 (en) * | 2010-07-30 | 2012-02-15 | Ferring B.V. | Stabilization of gonadotropins |
| JO3092B1 (ar) | 2011-08-08 | 2017-03-15 | Ferring Bv | مركب لتحفيز مسيطر عليه للمبيض |
| WO2015075743A1 (en) * | 2013-11-12 | 2015-05-28 | Cadila Healthcare Limited | Formulation for gonadotropins |
| CN105727260A (zh) * | 2016-02-03 | 2016-07-06 | 华侨大学 | 一种卵泡刺激素的长效制剂 |
| GB201603280D0 (en) | 2016-02-24 | 2016-04-13 | Ferring Bv | Stable liquid gonadotropin formulation |
| FR3083089A1 (fr) * | 2018-06-29 | 2020-01-03 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes |
| IL275148B2 (en) | 2017-12-07 | 2025-02-01 | Adocia | An injectable solution with a pH of 7 comprising at least one basic insulin with a PI between 5.8 and 8.5 and a copolyamino acid bearing carboxylate charges and hydrophobic radicals. |
| KR20200106891A (ko) | 2017-12-07 | 2020-09-15 | 아도시아 | pI가 5.8 내지 8.5인 적어도 1종의 기저 인슐린, 및 카복실산염 전하 및 소수성 라디칼을 보유하는 코-폴리아미노산을 포함하는 pH 7의 주사용 용액 |
| FR3084584B1 (fr) * | 2018-08-03 | 2020-11-06 | Adocia | Solution injectable a ph 7 comprenant du glucagon humain et un compose amphiphile porteur de radicaux hydrophobes |
| FR3084586B1 (fr) * | 2018-08-03 | 2020-11-06 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un compose amphiphile porteur de radicaux hydrophobes |
| JP7425459B2 (ja) * | 2019-10-11 | 2024-01-31 | 株式会社シノテスト | 安定化されたｈｍｇｂ１含有溶液 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996029095A1 (en) | 1995-03-21 | 1996-09-26 | Applied Research Systems Ars Holding N.V. | Hcg liquid formulations |
| CZ297042B6 (cs) * | 1996-05-29 | 2006-08-16 | Delsitechoy | Dodávkové zarízení pro pomalé uvolnování biologicky úcinného cinidla, jeho pouzití a farmaceutický prostredek s jeho obsahem |
| TW518235B (en) * | 1997-01-15 | 2003-01-21 | Akzo Nobel Nv | A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage |
| US20030166525A1 (en) * | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
| PL346127A1 (en) * | 1998-07-23 | 2002-01-28 | Lilly Co Eli | Fsh and fsh variant formulations, products and methods |
| UA89781C2 (uk) * | 2004-04-07 | 2010-03-10 | Арес Трейдінг С.А. | Рідкий склад гормона росту |
| KR101105871B1 (ko) * | 2005-09-27 | 2012-01-16 | 주식회사 엘지생명과학 | 인 난포자극호르몬의 안정한 용액 제형 |
| KR101573773B1 (ko) * | 2008-02-08 | 2015-12-02 | 바이오제너릭스 게엠베하 | Ｆｓｈ의 액체 포뮬레이션 |
| TWI488640B (zh) | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
| CN101614748A (zh) * | 2008-06-25 | 2009-12-30 | 上海新波生物技术有限公司 | 促卵泡激素时间分辨免疫荧光分析法及试剂盒 |
| JP5808323B2 (ja) * | 2009-06-22 | 2015-11-10 | アムジエン・インコーポレーテツド | 化学的に制御されたレドックス状態を用いたタンパク質のリフォールディング |
| EP2533800B1 (en) * | 2010-02-12 | 2016-07-20 | Intas Pharmaceuticals Ltd. | Liquid formulation of follicle stimulating hormone |
| EP2417982A1 (en) * | 2010-07-30 | 2012-02-15 | Ferring B.V. | Stabilization of gonadotropins |
-
2010
- 2010-07-30 EP EP10171428A patent/EP2417982A1/en not_active Withdrawn
-
2011
- 2011-07-21 JO JOP/2011/0231A patent/JO3229B1/ar active
- 2011-07-25 TW TW100126190A patent/TWI439283B/zh active
- 2011-07-28 CA CA2805864A patent/CA2805864A1/en active Pending
- 2011-07-28 RS RS20170265A patent/RS55772B1/sr unknown
- 2011-07-28 PL PL11736111T patent/PL2598160T3/pl unknown
- 2011-07-28 AU AU2011284702A patent/AU2011284702C1/en active Active
- 2011-07-28 RU RU2012157154/15A patent/RU2574012C2/ru active
- 2011-07-28 HU HUE11736111A patent/HUE033592T2/hu unknown
- 2011-07-28 WO PCT/EP2011/062986 patent/WO2012013742A2/en not_active Ceased
- 2011-07-28 DK DK11736111.3T patent/DK2598160T3/en active
- 2011-07-28 US US13/704,771 patent/US8993732B2/en active Active
- 2011-07-28 HR HRP20170386TT patent/HRP20170386T1/hr unknown
- 2011-07-28 ES ES11736111.3T patent/ES2623634T3/es active Active
- 2011-07-28 BR BR112013002312-0A patent/BR112013002312B1/pt active IP Right Grant
- 2011-07-28 PT PT117361113T patent/PT2598160T/pt unknown
- 2011-07-28 NZ NZ606366A patent/NZ606366A/en unknown
- 2011-07-28 KR KR1020137002504A patent/KR101820115B1/ko active Active
- 2011-07-28 JP JP2013521146A patent/JP5860047B2/ja active Active
- 2011-07-28 EP EP11736111.3A patent/EP2598160B1/en active Active
- 2011-07-28 LT LTEP11736111.3T patent/LT2598160T/lt unknown
- 2011-07-28 SI SI201131132A patent/SI2598160T1/sl unknown
- 2011-07-28 EP EP16195020.9A patent/EP3144010A1/en not_active Withdrawn
- 2011-07-28 CN CN201180037221.0A patent/CN103052398B/zh active Active
- 2011-07-28 CN CN201510508334.4A patent/CN105106939A/zh active Pending
- 2011-07-28 MX MX2016010733A patent/MX356951B/es unknown
- 2011-07-28 KR KR1020187001203A patent/KR101991756B1/ko active Active
- 2011-07-28 MX MX2013000681A patent/MX341464B/es active IP Right Grant
- 2011-07-28 NZ NZ628962A patent/NZ628962A/en unknown
- 2011-07-29 AR ARP110102766A patent/AR082776A1/es not_active Application Discontinuation
- 2011-07-30 SA SA114350786A patent/SA114350786B1/ar unknown
-
2012
- 2012-12-13 ZA ZA2012/09497A patent/ZA201209497B/en unknown
- 2012-12-24 IL IL223821A patent/IL223821A/en active IP Right Grant
-
2015
- 2015-02-25 US US14/631,382 patent/US9463221B2/en active Active
- 2015-12-17 JP JP2015245748A patent/JP2016102127A/ja active Pending
-
2016
- 2016-09-06 US US15/257,402 patent/US20170216405A1/en not_active Abandoned
-
2017
- 2017-01-03 IL IL249920A patent/IL249920A0/en unknown
- 2017-11-02 JP JP2017212395A patent/JP6522711B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013532677A5 (enExample) | ||
| RU2012157154A (ru) | Стабилизация fsh | |
| JP2014139241A5 (enExample) | ||
| RU2015122023A (ru) | Стабилизированная композиция пеметрекседа | |
| JP2014218522A5 (enExample) | ||
| RU2015132974A (ru) | Слезозаменитель, содержащий гиалуронат натрия и карбоксиметилцеллюлозу | |
| JP2014521659A5 (enExample) | ||
| AR081015A1 (es) | Formulaciones de galactomananos oftalmicas estabilizadas. metodo. | |
| PH12015501913A1 (en) | Substituted imidazopyridazines | |
| GB201307548D0 (en) | Agrochemical compositions for reducing agrochemical residues | |
| MX383411B (es) | Limpiador de horno de dosis unitaria de tableta sólida. | |
| JP2016503058A5 (enExample) | ||
| JP2017509623A5 (enExample) | ||
| CL2014000035A1 (es) | Composicion en forma de un gel para la preparacion de un producto alimenticio, que comprende agua en una cantidad de 30 a 70% en peso, saborizantes desde 1 a 40%, sal desde 10 a 25% y agentes gelificantes desde 0,15 a 12% que contienen al menos agar y xantano; y proceso para preparar dicha composicion. | |
| EP2987786A4 (en) | AMIDOPYRIDINOL DERIVATIVE OR PHARMACEUTICAL, SALT AND PHARMACEUTICAL COMPOSITION THEREFOR AS ACTIVE SUBSTANCE | |
| JP2018532806A5 (enExample) | ||
| WO2014203137A3 (en) | Pharmaceutical compositions of tamsulosin or salts thereof | |
| AR088918A1 (es) | Composiciones antitranspirantes anhidras | |
| HRP20191050T1 (hr) | Pripravak protiv virusnog konjunktivitisa koji sadrži jota-karagenan | |
| BR112015014137A2 (pt) | unidade sólida com alto teor de fexofenadina e processo para a preparação da mesma | |
| EA201170101A1 (ru) | Фармацевтические композиции роувастатина кальция | |
| CL2015001544A1 (es) | Método para fabricar sal mineral y producto de sal mineral | |
| RU2016137165A (ru) | Композиция для применения при лечении боли, связанной с межпозвоночным диском | |
| PH12015502717A1 (en) | Anti-fibrogenic compounds, methods and uses thereof | |
| PL420378A1 (pl) | Stabilizowany roztwór na bazie substancji czynnych, sposób otrzymywania stabilizowanego roztworu substancji czynnych, kompozycja farmaceutyczna na bazie stabilizowanego roztworu substancji czynnych (dwa warianty) |